Skip to main content

Table 9 Emergence from anesthesia

From: Comparison of dexmedetomidine vs. remifentanil combined with sevoflurane during radiofrequency ablation of hepatocellular carcinoma: a randomized controlled trial

 

Remifentanil (n = 47)

Dexmedetomidine (n = 47)

P

Patients with delayed emergence

2 (4.26)

6 (12.77)

0.267

Time to emergence (min)*

14 (11, 18)

15 (10, 24)

0.066

Time to extubation (min)*

19 (15, 25)

19 (15, 29)

0.051

Patients with SAS ≥ 5 at extubation

2 (4.26)

6 (12.77)

0.267

Patients with SAS ≥ 5 at 1 min after extubation

0 (0.00)

2 (4.26)

0.495

Patients with SAS ≥ 5 at 5 min after extubation

0 (0.00)

1 (2.13)

1.000

  1. Values expressed as numbers and percentages, or medians and interquartile ranges (25th percentile, 75th percentile)
  2. SAS Sedation-Agitation scale
  3. *Mann–Whitney U-test
Back to article page

Trials

ISSN: 1745-6215